Exploring exercise as an avenue for the treatment of anxiety disorders

Expert Review of Neurotherapeutics

Volumn 12, Issue 8, 2012, Pages 1011-1022

  Deboer, Lindsey B ^a   Powers, Mark B ^a   Utschig, Angela C ^b   Otto, Michael W ^b   Smits, Jasper A J ^a  

^a SOUTHERN METHODIST UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

anxiety; anxiety disorders; exercise; intervention; physical activity; treatment

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BENZODIAZEPINE DERIVATIVE; BETA ENDORPHIN; BRAIN DERIVED NEUROTROPHIC FACTOR; ENDORPHIN; NEUROTRANSMITTER; YOHIMBINE;

AEROBIC EXERCISE; ANXIETY DISORDER; BICYCLE ERGOMETRY; COGNITIVE THERAPY; CORE TEMPERATURE; EMOTION; EXERCISE; GENERALIZED ANXIETY DISORDER; HUMAN; LEARNING; NONHUMAN; PANIC; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; REVIEW; SELF CONCEPT; SOCIAL PHOBIA; TRANQUILIZING ACTIVITY; TREADMILL EXERCISE; TREATMENT OUTCOME; WALKING; YOGA;

ACTIVITIES OF DAILY LIVING; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BRAIN CHEMISTRY; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; EMOTIONAL INTELLIGENCE; EVIDENCE-BASED MEDICINE; EXERCISE; EXTINCTION, PSYCHOLOGICAL; HUMANS; INDIVIDUALIZED MEDICINE; MOTOR ACTIVITY; SELF EFFICACY;

EID: 84866689026     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.73     Document Type: Review

References (163)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62(6), 617-627 (2005).
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62(6), 593-602 (2005).
3. Buist-Bouwman MA, De Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J; ESEMeD/MHEDEA 2000 Investigators. Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr. Scand. 113(6), 492-500 (2006).
4. Greenberg PE, Sisitsky T, Kessler RC et al. The economic burden of anxiety disorders in the 1990s. J. Clin. Psychiatry 60(7), 427-435 (1999).
5. Leon AC, Portera L, Weissman MM. The social costs of anxiety disorders. Br. J. Psychiatry. Suppl. (27) 19-22 (1995).
6. Schneider S, Houweling JE, Gommlich-Schneider S, Klein C, Nndel B, Wolke D. Effect of maternal panic disorder on mother-child interaction and relation to child anxiety and child self-efficacy. Arch. Womens Ment. Health 12(4), 251-259 (2009).
7. Zaider TI, Heimberg RG, Iida M. Anxiety disorders and intimate relationships: a study of daily processes in couples. J. Abnorm. Psychol. 119(1), 163-173 (2010).
8. Hofmann SG, Smits JA. Cognitivebehavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J. Clin. Psychiatry 69(4), 621-632 (2008).
9. Powers MB, Emmelkamp PM. Virtual reality exposure therapy for anxiety disorders: a meta-analysis. J. Anxiety Disord. 22(3), 561-569 (2008).
10. Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, Foa EB. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin. Psychol. Rev. 30(6), 635-641 (2010).
11. Powers MB, Sigmarsson SR, Emmelkamp PMG. A meta-analytic review of psychological treatments for social anxiety disorder. Int. J. Cognitive Ther., 12, 94-113 (2008).
12. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 283(19), 2529-2536 (2000).
13. Borkovec TD, Newman MG, Pincus AL, Lytle R. A component analysis of cognitive-behavioral therapy for generalized anxiety disorder and the role of interpersonal problems. J. Consult. Clin. Psychol. 70(2), 288-298 (2002).
14. Davidson JR, Foa EB, Huppert JD et al. Fluoxetine, comprehensive cognitivebehavioral therapy, and placebo in generalized social phobia. Arch. Gen. Psychiatry 61(10), 1005-1013 (2004).
15. Foa EB, Liebowitz MR, Kozak MJ et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am. J. Psychiatry 162(1), 151-161 (2005).
16. Marks I, Lovell K, Noshirvani H, Livanou M, Thrasher S. Treatment of posttraumatic stress disorder by exposure and/or cognitive-restructuring: a controlled study. Arch. Gen. Psychiatry 55(4), 317-325 (1998).
17. Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am. J. Public Health 92(1), 92-98 (2002).
18. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62(6), 629-640 (2005).
19. Becker CB, Zayfert C, Anderson E. A survey of psychologists attitudes towards and utilization of exposure therapy for PTSD. Behav. Res. Ther. 42(3), 277-292 (2004).
20. Freiheit SR, Vye C, Swan R, Cady M. Cognitive-behavioral therapy for anxiety: is dissemination working? Behav. Ther. 27(2), 25-32 (2004).
21. Rosen CS, Chow HC, Finney JF et al. VA practice patterns and practice guidelines for treating posttraumatic stress disorder. J. Trauma. Stress 17(3), 213-222 (2004).
22. Hunter LR, Schmidt NB. Anxiety psychopathology in African American adults: literature review and development of an empirically informed sociocultural model. Psychol. Bull. 136(2), 211-235 (2010).
23. Overton SL, Medina SL. The stigma of mental illness. J. Couns. Dev. 86(2), 143-151 (2008).
24. Choy Y. Managing side effects of anxiolytics. Prof. Psychol. 14(7), 68-76 (2007).
25. Golden RN. Making advances where it matters: improving outcomes in mood and anxiety disorders. CNS Spectr. 9(6 Suppl. 4), 14-22 (2004).
26. Mavissakalian M, Perel J, Guo S. Specific side effects of long-term imipramine management of panic disorder. J. Clin. Psychopharmacol. 22(2), 155-161 (2002).
27. Rivas-Vazquez RA. Benzodiazepines in contemporary clinical practice. Prof. Psychol: Res. Pr. 34(3), 324-328 (2003).
28. Broocks A, Bandelow B, George A et al. Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder. Int. Clin. Psychopharmacol. 15(3), 153-161 (2000).
29. Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berl.) 96(3), 360-364 (1988).
30. Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res. 25(1), 101-104 (1988).
31. Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Schoellnhammer G, Schulte HM. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci. 46(18), 1271-1277 (1990).
32. Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures. Eur. Arch. Psychiatry Clin. Neurosci. 241(6), 337-344 (1992).
33. Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. Eur. Arch. Psychiatry Clin. Neurosci. 241(6), 345-351 (1992).
34. Charney DS, Heninger GR. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry 43(11), 1042-1054 (1986).
35. Charney DS, Woods SW, Goodman WK, Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am. J. Psychiatry 144(8), 1030-1036 (1987).
36. Yeragani VK, Tancer M, Uhde T. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res. 121(2), 185-196 (2003).
37. Chaouloff F. Effects of acute physical exercise on central serotonergic systems. Med. Sci. Sports Exerc. 29(1), 58-62 (1997).
38. Broocks A, Schweiger U, Pirke KM. The influence of semistarvation-induced hyperactivity on hypothalamic serotonin metabolism. Physiol. Behav. 50(2), 385-388 (1991).
39. Broocks A, Meyer T, George A et al. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners. Neuropsychopharmacology 20(2), 150-161 (1999).
40. Broocks A, Meyer T, Gleiter CH et al. Effect of aerobic exercise on behavioral and neuroendocrine responses to metachlorophenylpiperazine and to ipsapirone in untrained healthy subjects. Psychopharmacology (Berl.) 155(3), 234-241 (2001).
41. Broocks A, Liu J, Pirke KM. Semistarvationinduced hyperactivity compensates for decreased norepinephrine and dopamine turnover in the mediobasal hypothalamus of the rat. J. Neural Transm. Gen. Sect. 79(1-2), 113-124 (1990).
42. Morishima M, Harada N, Hara S et al. Monoamine oxidase A activity and norepinephrine level in hippocampus determine hyperwheel running in SPORTS rats. Neuropsychopharmacology 31(12), 2627-2638 (2006).
43. Sommer M, Braumann M, Althoff T et al. Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controls. Pharmacopsychiatry 44(4), 129-134 (2011).
44. Dishman RK, Armstrong RB, Delp MD, Graham RE, Dunn AL. Open-field behavior is not related to treadmill performance in exercising rats. Physiol. Behav. 43(5), 541-546 (1988).
45. Morgan WP, Olson EB Jr, Pedersen NP. A rat model of psychopathology for use in exercise science. Med. Sci. Sports Exerc. 14(1), 91-100 (1982).
46. Royce J.R. On the construct validity of open-field measures. Psychol. Bull. 84(6), 1098-1106 (1977).
47. Jones DL, Mogenson GJ. Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am. J. Physiol. 238(1), R65-R69 (1980).
48. Jones DL, Mogenson GJ, Wu M. Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat. Neuropharmacology 20(1), 29-37 (1981).
49. Tharp GD, Carson WH. Emotionality changes in rats following chronic exercise. Med. Sci. Sports 7(2), 123-126 (1975).
50. Weber JC, Lee RA. Effects of differing prepuberty exercise programs on the emotionality of male albino rats. Res. Q. 39(3), 748-751 (1968).
51. Dishman RK, Dunn AL, Youngstedt SD et al. Increased open-field locomotion and decreased striatal GABAA binding after activity wheel running. Physiol. Behav. 60(3), 699-705 (1996).
52. Streeter CC, Jensen JE, Perlmutter RM et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J. Altern. Complement. Med. 13(4), 419-426 (2007).
53. Streeter CC, Whitfield TH, Owen L et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J. Altern. Complement. Med. 16(11), 1145-1152 (2010).
54. Strhle A, Feller C, Strasburger CJ, Heinz A, Dimeo F. Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide. Psychoneuroendocrinology 31(9), 1127-1130 (2006).
55. Strhle A, Jahn H, Montkowski A et al. Central and peripheral administration of atriopeptin is anxiolytic in rats. Neuroendocrinology 65(3), 210-215 (1997).
56. Strhle A, Kellner M, Holsboer F, Wiedemann K. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am. J. Psychiatry 158(9), 1514-1516 (2001).
57. Mandroukas K, Zakas A, Aggelopoulou N, Christoulas K, Abatzides G, Karamouzis M. Atrial natriuretic factor responses to submaximal and maximal exercise. Br. J. Sports Med. 29(4), 248-251 (1995).
58. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, posttraumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav. Pharmacol. 21(5-6), 427-437 (2010).
59. Nagahara AH, Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 10(3), 209-219 (2011).
60. Cirulli F, Berry A, Chiarotti F, Alleva E. Intrahippocampal administration of BDNF in adult rats affects short-term behavioral plasticity in the Morris water maze and performance in the elevated plus-maze. Hippocampus 14(7), 802-807 (2004).
61. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2), 257-269 (2003).
62. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 12(7), 656-670 (2007).
63. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11(8), 1169-1180 (2008).
64. Dellosso L, Carmassi C, Del Debbio A et al. Brain-derived neurotrophic factor plasma levels in patients suffering from posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 33(5), 899-902 (2009).
65. Piccinni A, Marazziti D, Catena M et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disord. 105(1-3), 279-283 (2008).
66. Chen ZY, Jing D, Bath KG et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314(5796), 140-143 (2006).
67. Strhle A, Stoy M, Graetz B et al. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 35(3), 364-368 (2010).
68. Kobayashi K, Shimizu E, Hashimoto K et al. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive-behavioral therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 29(5), 658-663 (2005).
69. Goekint M, Heyman E, Roelands B et al. No influence of noradrenaline manipulation on acute exercise-induced increase of brain-derived neurotrophic factor. Med. Sci. Sports Exerc. 40(11), 1990-1996 (2008).
70. Gold SM, Schulz KH, Hartmann S et al. Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J. Neuroimmunol. 138(1-2), 99-105 (2003).
71. Gustafsson G, Lira CM, Johansson J et al. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res. 169(3), 244-248 (2009).
72. Laske C, Banschbach S, Stransky E et al. Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int. J. Neuropsychopharmacol. 13(5), 595-602 (2010).
73. Ferris LT, Williams JS, Shen CL. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med. Sci. Sports Exerc. 39(4), 728-734 (2007).
74. Schiffer T, Schulte S, Sperlich B, Achtzehn S, Fricke H, Strder HK. Lactate infusion at rest increases BDNF blood concentration in humans. Neurosci. Lett. 488(3), 234-237 (2011).
75. Rojas Vega S, Strder HK, Vera Wahrmann B, Schmidt A, Bloch W, Hollmann W. Acute BDNF and cortisol response to low intensity exercise and following ramp incremental exercise to exhaustion in humans. Brain Res. 1121(1), 59-65 (2006).
76. Winter B, Breitenstein C, Mooren FC et al. High impact running improves learning. Neurobiol. Learn. Mem. 87(4), 597-609 (2007).
77. Dishman RK, OConnor PJ. Lessons in exercise neurobiology: the case of endorphins. Ment. Health Phys. Act. 2(1), 4-9 (2009).
78. Farrell PA, Gustafson AB, Garthwaite TL, Kalkhoff RK, Cowley AW Jr, Morgan WP. Influence of endogenous opioids on the response of selected hormones to exercise in humans. J. Appl. Physiol. 61(3), 1051-1057 (1986).
79. Markoff RA, Ryan P, Young T. Endorphins and mood changes in long-distance running. Med. Sci. Sports Exerc. 14(1), 11-15 (1982).
80. Sforzo GA. Opioids and exercise. An update. Sports Med. 7(2), 109-124 (1989).
81. Boecker H, Sprenger T, Spilker ME et al. The runners high: opioidergic mechanisms in the human brain. Cereb. Cortex 18(11), 2523-2531 (2008).
82. Cunha RA, Ferr S, Vaugeois JM, Chen JF. Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr. Pharm. Des. 14(15), 1512-1524 (2008).
83. Meeusen R, Piacentini MF, De Meirleir K. Brain microdialysis in exercise research. Sports Med. 31(14), 965-983 (2001).
84. Costa MS, Ardais AP, Fioreze GT et al. Treadmill running frequency on anxiety and hippocampal adenosine receptors density in adult and middle-aged rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 36(1), 198-204 (2012).
85. Crabbe JB, Dishman RK. Brain electrocortical activity during and after exercise: a quantitative synthesis. Psychophysiology 41(4), 563-574 (2004).
86. Koltyn KF, Schultes SS. Psychological effects of an aerobic exercise session and a rest session following pregnancy. J. Sports Med. Phys. Fitness 37(4), 287-291 (1997).
87. deVries HA. Tension reduction with exercise. In: Exercise and Mental Health. Morgan WP, Goldston SE (Eds). Hemisphere Publishing Corp., Washington, DC, USA, 99-104 (1987).
88. Morgan WP, OConnor PJ. Exercise and mental health. In: Exercise Adherence: Its Impact on Public Health. Dishman RK (Ed.). Human Kinetics, IL, USA, 91-121 (1988).
89. Raglin JS, Morgan WP. Influence of vigorous exercise on mood state. Behav. Ther. 8, 179-183 (1985).
90. Koltyn KF, Morgan WP. Influence of wet suit wear on anxiety responses to underwater exercise. Undersea Hyperb. Med. 24(1), 23-28 (1997).
91. Petruzzello SJ, Landers DM, Salazar W. Exercise and anxiety reduction: examination of temperature as an explanation for affective change. J. Sport Exercise Psy. 15, 63-76 (1993).
92. Reeves DL, Levinson DM, Justesen DR, Lubin B. Endogenous hyperthermia in normal human subjects: experimental study of emotional states (II). Int. J. Psychosom. 32(4), 18-23 (1985).
93. Anderson KC, Insel TR. The promise of extinction research for the prevention and treatment of anxiety disorders. Biol. Psychiatry 60(4), 319-321 (2006).
94. Bouton ME. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol. Psychiatry 52(10), 976-986 (2002).
95. Myers KM, Davis M. Mechanisms of fear extinction. Mol. Psychiatry 12(2), 120-150 (2007).
96. Pavlov IP. Conditioned Reflexes. Oxford University Press, London, UK (1927).
97. Foa EB, Chambless DL. Habituation of subjective anxiety during flooding in imagery. Behav. Res. Ther. 16(6), 391-399 (1978).
98. Watson JP, Gaind R, Marks IM. Physiological habituation to continuous phobic stimulation. Behav. Res. Ther. 10(3), 269-278 (1972).
99. Smits JAJ, Powers MB, Berry AC, Otto MW. Translating empirically supported strategies into accessible interventions: the potential utility of exercise for the treatment of panic disorder. Cogn. Behav. Pract. 14(4), 364-374 (2007).
100. McNally RJ. Anxiety sensitivity and panic disorder. Biol. Psychiatry 52(10), 938-946 (2002).
101. Gardenswartz CA, Craske MG. Prevention of panic disorder. Behav. Ther. 32, 725-737 (2001).
102. Smits JA, Powers MB, Cho Y, Telch MJ. Mechanism of change in cognitivebehavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis. J. Consult. Clin. Psychol. 72(4), 646-652 (2004).
103. Smits JA, Berry AC, Rosenfield D, Powers MB, Behar E, Otto MW. Reducing anxiety sensitivity with exercise. Depress. Anxiety 25(8), 689-699 (2008).
104. Broman-Fulks JJ, Berman ME, Rabian BA, Webster MJ. Effects of aerobic exercise on anxiety sensitivity. Behav. Res. Ther. 42(2), 125-136 (2004).
105. Broman-Fulks JJ, Storey KM. Evaluation of a brief aerobic exercise intervention for high anxiety sensitivity. Anxiety. Stress. Coping 21(2), 117-128 (2008).
106. Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav. Ther. 35, 205-230 (2004).
107. Stathopoulou G, Powers MB, Berry AC, Smits JAJ, Otto MW. Exercise interventions for mental health: a quantitative and qualitative review. Clin. Psychol. Sci. Pr. 13(2), 179-193 (2006).
108. Moses J, Steptoe A, Mathews A, Edwards S. The effects of exercise training on mental well-being in the normal population: a controlled trial. J. Psychosom. Res. 33(1), 47-61 (1989).
109. Bodin T, Martinsen EW. Mood and self-efficacy during acute exercise in clinical depression. A randomized, controlled study. J. Sport. Exercise Psy. 26, 623-633 (2004).
110. McAuley E, Doerksen SE, Morris KS et al. Pathways from physical activity to quality of life in older women. Ann. Behav. Med. 36(1), 13-20 (2008).
111. Katula JA, Blissmer BJ, McAuley E. Exercise intensity and self-efficacy effects on anxiety reduction in healthy, older adults. J. Behav. Med. 22(3), 233-247 (1999).
112. Spielberger CD, Gorusch RL, Luschene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, CA, USA (1983).
113. Ekkekakis P, Petruzzello SJ. Acute aerobic exercise and affect: current status, problems and prospects regarding dose-response. Sports Med. 28(5), 337-374 (1999).
114. Marquez DX, Jerome GJ, McAuley E, Snook EM, Canaklisova S. Self-efficacy manipulation and state anxiety responses to exercise in low active women. Psychol. Health. 17(6), 783-791 (2002).
115. McAuley E, Courneya KS, Rudolph DL, Lox CL. Enhancing exercise adherence in middle-aged males and females. Prev. Med. 23(4), 498-506 (1994).
116. Bahrke MS, Morgan WP. Anxiety reduction following exercise and meditation. Cognitive Ther. Res. 2(4), 323-333 (1978).
117. Breus MJ, OConnor PJ. Exercise-induced anxiolysis: a test of the time-out hypothesis in high anxious females. Med. Sci. Sports Exerc. 30(7), 1107-1112 (1998).
118. Hassmn P, Koivula N, Uutela A. Physical exercise and psychological well-being: a population study in Finland. Prev. Med. 30(1), 17-25 (2000).
119. Goodwin RD. Association between physical activity and mental disorders among adults in the United States. Prev. Med. 36(6), 698-703 (2003).
120. Strhle A, Hfler M, Pfister H et al. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol. Med. 37(11), 1657-1666 (2007).
121. Schmitz N, Kruse J, Kugler J. The association between physical exercises and health-related quality of life in subjects with mental disorders: results from a cross-sectional survey. Prev. Med. 39(6), 1200-1207 (2004).
122. Esquivel G, Schruers K, Kuipers H, Griez E. The effects of acute exercise and high lactate levels on 35% CO2 challenge in healthy volunteers. Acta Psychiatr. Scand. 106(5), 394-397 (2002).
123. Strhle A, Feller C, Onken M, Godemann F, Heinz A, Dimeo F. The acute antipanic activity of aerobic exercise. Am. J. Psychiatry 162(12), 2376-2378 (2005).
124. Smits JA, Meuret AE, Zvolensky MJ, Rosenfield D, Seidel A. The effects of acute exercise on CO(2) challenge reactivity. J. Psychiatr. Res. 43(4), 446-454 (2009).
125. Esquivel G, D-az-Galvis J, Schruers K, Berlanga C, Lara-Muoz C, Griez E. Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic disorder. J. Affect. Disord. 107(1-3), 217-220 (2008).
126. Strhle A, Graetz B, Scheel M et al. The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects. J. Psychiatr. Res. 43(12), 1013-1017 (2009).
127. Garvin AW, Koltyn KF, Morgan WP. Influence of acute physical activity and relaxation on state anxiety and blood lactate in untrained college males. Int. J. Sports Med. 18(6), 470-476 (1997).
128. Grosz HJ, Farmer BB. Blood lactate in the development of anxiety symptoms. A critical examination of Pitts and McClures hypothesis and experimental study. Arch. Gen. Psychiatry 21(5), 611-619 (1969).
129. OConnor PJ, Smith JC, Morgan WP. Physical activity does not provoke panic attacks in patients with panic disorder: a review of the evidence. Anxiety, Stress Coping. 13(4), 333-353 (2000).
130. Pitts FN Jr. The biochemistry of anxiety. Sci. Am. 220(2), 69-75 (1969).
131. Pitts FN Jr, McClure JN Jr. Lactate metabolism in anxiety neurosis. N. Engl. J. Med. 277(25), 1329-1336 (1967).
132. Wipfli BM, Rethorst CD, Landers DM. The anxiolytic effects of exercise: a meta-analysis of randomized trials and dose-response analysis. J. Sport Exerc. Psychol. 30(4), 392-410 (2008).
133. Broocks A, Bandelow B, Pekrun G et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am. J. Psychiatry 155(5), 603-609 (1998).
134. Merom D, Phongsavan P, Wagner R et al. Promoting walking as an adjunct intervention to group cognitive-behavioral therapy for anxiety disorders -a pilot group randomized trial. J. Anxiety Disord. 22(6), 959-968 (2008).
135. Martinsen EW, Hoffart A, Solberg Y. Aerobic and nonaerobic forms of exercise in the treatment of anxiety disorders. Stress. Med. 5(2), 115-120 (1989).
136. Brown RA, Abrantes AM, Strong DR et al. A pilot study of moderate-intensity aerobic exercise for obsessive-compulsive disorder. J. Nerv. Ment. Dis. 195(6), 514-520 (2007).
137. Diaz AB, Motta R. The effects of an aerobic exercise program on posttraumatic stress disorder symptom severity in adolescents. Int. J. Emerg. Ment. Health 10(1), 49-59 (2008).
138. Newman CL, Motta RW. The effects of aerobic exercise on childhood PTSD, anxiety, and depression. Int. J. Emerg. Ment. Health 9(2), 133-158 (2007).
139. Hale BS, Raglin JS. State anxiety responses to acute resistance training and step aerobic exercise across eight weeks of training. J. Sports Med. Phys. Fitness 42(1), 108-112 (2002).
140. Raglin JS, Wilson M. State anxiety following 20 minutes of bicycle ergometer exercise at selected intensities. Int. J. Sports Med. 17(6), 467-471 (1996).
141. Bibeau WS, Moore JB, Mitchell NG, Vargas-Tonsing T, Bartholomew JB. Effects of acute resistance training of different intensities and rest periods on anxiety and affect. J. Strength Cond. Res. 24(8), 2184-2191 (2010).
142. Raglin JS, Turner PE, Eksten F. State anxiety and blood pressure following 30 min of leg ergometry or weight training. Med. Sci. Sports Exerc. 25(9), 1044-1048 (1993).
143. Koltyn KF, Raglin JS, OConnor PJ, Morgan WP. Influence of weight training on state anxiety, body awareness and blood pressure. Int. J. Sports Med. 16(4), 266-269 (1995).
144. Cassilhas RC, Antunes HK, Tufik S, de Mello MT. Mood, anxiety, and serum IGF-1 in elderly men given 24 weeks of high resistance exercise. Percept. Mot. Skills 110(1), 265-276 (2010).
145. Tsutsumi T, Don BM, Zaichkowsky LD, Takenaka K, Oka K, Ohno T. Comparison of high and moderate-intensity of strength training on mood and anxiety in older adults. Percept. Mot. Skills 87(3 Pt 1), 1003-1011 (1998).
146. Tsutsumi T, Don BM, Zaichkowsky LD, Delizonna LL. Physical fitness and psychological benefits of strength training in community dwelling older adults. Appl. Human Sci. 16(6), 257-266 (1997).
147. Field T, Diego M, Hernandez-Reif M. Tai chi/yoga effects on anxiety, heartrate, EEG and math computations. Complement. Ther. Clin. Pract. 16(4), 235-238 (2010).
148. Petruzzello SJ, Landers DM, Hatfield BD, Kubitz KA, Salazar W. A meta-analysis on the anxiety-reducing effects of acute and chronic exercise. Outcomes and mechanisms. Sports Med. 11(3), 143-182 (1991).
149. Wipfli BM, Rethorst CD, Landers DM. The anxiolytic effects of exercise: a meta-analysis of randomized trials and dose-response analysis. J. Sport Exerc. Psychol. 30(4), 392-410 (2008).
150. OConnor PJ, Raglin JS, Morgan WP. Psychometric correlates of perception during arm ergometry in males and females. Int. J. Sports Med. 17(6), 462-466 (1996).
151. Williams DM, Dunsiger S, Ciccolo JT, Lewis BA, Albrecht AE, Marcus BH. Acute affective response to a moderateintensity exercise stimulus predicts physical activity participation 6 and 12 months later. Psychol. Sport Exerc. 9(3), 231-245 (2008).
152. Otto MW, Smits JAJ. Exercise for Mood and Anxiety: Proven Strategies for Overcoming Depression and Enhancing Well-Being. Oxford University Press, NY, USA (2011).
153. Dishman RK. Increasing and maintaining exercise and physical activity. Behav. Ther. 22(3), 345-378 (1991).
154. Smits JA, Tart CD, Presnell K, Rosenfield D, Otto MW. Identifying potential barriers to physical activity adherence: anxiety sensitivity and body mass as predictors of fear during exercise. Cogn. Behav. Ther. 39(1), 28-36 (2010).
155. Atalay A, Genz T. Critical factors of social physique anxiety: exercising and body image satisfaction. Behav. Change. 25(3), 178-188 (2008).
156. Ekkekakis P, Lind E, Vazou S. Affective responses to increasing levels of exercise intensity in normal-weight, overweight, and obese middle-aged women. Obesity (Silver Spring) 18(1), 79-85 (2010).
157. Mata J, Thompson RJ, Gotlib IH. BDNF genotype moderates the relation between physical activity and depressive symptoms. Health Psychol. 29(2), 130-133 (2010).
158. Toups MS, Greer TL, Kurian BT et al. Effects of serum Brain-Derived Neurotrophic Factor on exercise augmentation treatment of depression. J. Psychiatr. Res. 45(10), 1301-1306 (2011).
159. Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analyses. Clin. Psychol-Sci. Pr. 12, 72-86 (2005).
160. Marcus BH, Albrecht AE, King TK et al. The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Arch. Intern. Med. 159(11), 1229-1234 (1999).
161. Smits JA, Hofmann SG. A meta-analytic review of the effects of psychotherapy control conditions for anxiety disorders. Psychol. Med. 39(2), 229-239 (2009).
162. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu. Rev. Clin. Psychol. 3, 1-27 (2007).
163. Smits JA, Rosenfield D, McDonald R, Telch MJ. Cognitive mechanisms of social anxiety reduction: an examination of specificity and temporality. J. Consult. Clin. Psychol. 74(6), 1203-1212 (2006).